Merck & Co.

Merck & Co. Common Stock

About This Listing

Global pharmaceutical company known for Keytruda cancer immunotherapy, Gardasil vaccine, and animal health products through Organon.

Company Financials

Annual Revenue $92,000.00M
Net Profit $77,000.00M
Company Valuation $1,872,000.00M
Market Cap $9.37M

Price History

Current Price

$120.08

Available Shares 21,520
Total Shares 78,000
Min Purchase 1
Max Purchase 5,000
72% sold 56,480 / 78,000

Related Listings